GlassScriptPhysician profile
Stephanie Corrado
NPI 1871998476
$4,112.81
in general payments reported to CMS, 2019-2025
24 companies · $866 in 2025
The $866 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $897 · 2022: $341 · 2023: $788 · 2024: $1,221 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,874.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $1,408.09 | 2023-2025 | Reactiv8 |
| Boston Scientific Corporation | $445.67 | 2023-2025 | Intracept, General - Pain Management |
| Allergan, INC. | $275.01 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $199.36 | 2021-2023 | Xtampza |
| Saluda Medical Americas, INC. | $189.89 | 2023-2024 | Evoke Scs, Evoke |
| Relievant Medsystems, INC. | $168.08 | 2023 | Intracept |
| Scilex Pharmaceuticals INC. | $145.94 | 2021-2024 | |
| Virtus Pharmaceuticals LLC | $129.27 | 2021 | |
| Spinal Simplicity, LLC | $124.89 | 2025 | Ha Minuteman G3-R |
| Abbott Laboratories | $115.38 | 2023 | Proclaim |
| Biotronik Nro, INC. | $113.21 | 2025 | Prospera |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.13 | 2021-2022 | |
| Nalu Medical, INC. | $109.38 | 2024 | Nalu Neurostimulation System |
| Biodelivery Sciences International, INC. | $97.69 | 2021 | |
| Nevro Corp. | $97.09 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $87.85 | 2022 | |
| Abbvie INC. | $73.73 | 2022-2024 | |
| Redhill Biopharma INC. | $47.25 | 2021 | |
| Forte Bio-Pharma LLC | $38.41 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $36.66 | 2021 | |
| Lundbeck LLC | $35.39 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.42 | 2022 | |
| Amgen INC. | $19.95 | 2021 | |
| Inspire Medical Systems, INC. | $18.07 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Corrado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.